Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI

(SAN)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Sanofi : $82.99 Million Federal Contract Awarded to Sanofi Pasteur

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/12/2019 | 02:41am EDT

ATLANTA, Georgia, Jan. 11 -- Sanofi Pasteur Inc., Swiftwater, Pennsylvania, won an $82,991,898 federal contract from the U.S. Department of Health and Human Services' Centers for Disease Control and Prevention for adult influenza vaccines.

Agency contacts: Monica D. Shaw, 770/488-8213, monica.shaw@cdc.hhs.gov; or Pellumbeshe Hoxhaj, 770/488-2805, kfx2@cdc.gov. CIV5FCA5. CLASS65; NAICS325412.

For more information about Targeted News Service's products, including its daily federal contract report, please contact: Myron Struck, Myron@targetednews.com, Editor, Targeted News Service LLC, Springfield, Va., Direct: 703/866-4708, Cell: 703/304-1897.

© 2019 Targeted News Service, source News Service

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SANOFI
06/18SANOFI : Press releases
PU
06/18Sanofi, Google to Develop Healthcare Innovation Lab
DJ
06/18SANOFI : and Google to develop new healthcare Innovation Lab                    ..
GL
06/18SANOFI : and Google to develop new healthcare Innovation Lab                    ..
AQ
06/18SANOFI : and Google to develop new healthcare Innovation Lab                    ..
AQ
06/18Sanofi and Google to develop new healthcare Innovation Lab                   ..
GL
06/17Voyager Therapeutics Up 9%; Restructures Relationship with Sanofi Genzyme
DJ
06/17Voyager Therapeutics Restructures Gene Therapy Relationship with Sanofi Genzy..
DJ
06/12SANOFI : announces positive data from Soliquas diabetes trial
AQ
06/11SANOFI : talks up personalized diabetes care in patient-centric awareness push
AQ
More news
Financials (€)
Sales 2019 36 127 M
EBIT 2019 9 112 M
Net income 2019 4 955 M
Debt 2019 14 481 M
Yield 2019 3,98%
P/E ratio 2019 18,54
P/E ratio 2020 16,18
EV / Sales 2019 3,11x
EV / Sales 2020 2,92x
Capitalization 97 908 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 83,5 €
Spread / Average Target 6,7%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jean-Baptiste Chasseloup de Chatillon Chief Financial Officer & Executive Vice President
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI2.39%103 743
JOHNSON & JOHNSON8.05%348 981
PFIZER-1.76%233 072
ROCHE HOLDING LTD.14.56%227 848
NOVARTIS23.07%220 893
MERCK AND COMPANY9.02%206 641